Nitto Avecia Inc. has successfully completed the first synthesis runs at 1.6 Mol scale at its new oligonucleotide manufacturing facility in Milford, MA. According to the company, this is believed to be the largest synthesis scale executed for oligonucleotide API (active pharmaceutical ingredients). The company recently began operations with its new API manufacturing synthesis capabilities. This manufacturing capacity expansion increases Avecia’s total synthesis capacity to more than 3...